Related Experiment Video
Updated: Jan 17, 2026

Quantification of Diabetes-induced Adherent Leukocytes in Retinal Vasculature
Published on: January 24, 2025
Idiopathic Retinitis Vasculitis Aneurysms and Neuroretinitis (IRVAN) Treated with Adalimumab: A case report
L Van Winckel1, I Casteels2, P P Schauwvlieghe2
1Faculty of Medicine, KU Leuven, Leuven, Belgium.
Purpose:
To report a case of idiopathic retinal vasculitis, aneurysm, and neuroretinitis (IRVAN) syndrome with good response to treatment with Adalimumab in addition to panretinal photocoagulation (PRP).
Methods:
Case report.
Results:
We describe a case of IRVAN in an adolescent who had been initially treated with PRP and intravitreal injections of Ranibizumab in both eyes. Due to persistent retinal ischemia and vasculitis, treatment with subcutaneous injections of Adalimumab was initiated. After 1.5 years of follow-up, there was resolution of retinal vasculitis, and reversal of some retinal capillary non-perfusion with substantial regression of retinal ischemia.
Conclusion:
Treatment with Adalimumab may be useful in controlling disease activity in patients with IRVAN syndrome.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

